Physicochemical characterization of protamine-phosphorothioate nanoparticles

References

• ANDO, T., YAMASAKI, M., and SuzuK), K., 1973, Protamines: Isolation, characterisation, structure and function (Berlin, Heidelberg, New York: Springer Verlag).
   Google Scholar
• ASKARI, F. K., and MCDONNELL, W. M., 1996, Antisense-oligonucleotide therapy. New England Journal of Medicine, 334, 316–318.
   PubMed Web of Science ®Google Scholar
• AUSSERER, W. A., and BIROS, M. L., 1995, High-resolution analysis and purification of synthetic oligonucleotides with strong anion-exchange HPLC. Biotechniques, 19, 136–139.
   PubMed Web of Science ®Google Scholar
• BERGOT, B. J., and ZON, G., 1992, Separation of synthetic phosphorothioate oligo-nucleotides from phosphodiester-defect species by strong-anion exchange HPLC. Annals of the New York Academy of Science, 660, 310–312.
   PubMed Web of Science ®Google Scholar
• BERNE, B. J., and PECORA, R., 2000, Dynamic Light Scattering—With Applications to Chemistry, Biology, and Physics (Mineola, New York: Dover Publications).
   Google Scholar
• COUVREUR, P., and MALVY, C., 2000, Pharmaceutical Aspects of Oligonuceotides (London: Taylor & Francis).
   Google Scholar
• DE BREE, F., 2001. Genomic-based drugs in R&D-the promise of a new era. Genomic-based Drug Data Report and Regenerative Therapy, 1, 17–29.
   Google Scholar
• DE SMEDT, S. C., DEMEESTER, J., and HENNINK, W. E., 2000, Cationic polymer based gene delivery systems. Pharmceutical Research, 17, 113–126.
   PubMed Web of Science ®Google Scholar
• EISENBERG, H., 1976, Biological Macromolecules and Polyelectrolytes in Solution (Oxford: Clarendon Press).
   Google Scholar
• FATTAL, E., VAUTHIER, C., AYNIE, I., NAKADA, Y., LAMBERT, G., MALVY, C., and COUVREUR, P., 1998, Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. Journal of Controlled Release, 53, 137–143.
   PubMed Web of Science ®Google Scholar
• FUJITA, H., 1975, Ultracentrifugation in biochemistry (New York: John Wiley & Sons). GEWIRTZ, A. M., SOKOL, D. L., and RATAJCZAK, M. Z., 1998, Nucleic acid therapeutics: state of the art and future prospects. Blood, 92, 712–736.
   Google Scholar
• GONZALEZ FERREIRO, M., CROOKE, R. M., TILLMAN, L., HARDEE, G., and BODMEIER, R., 2003, Stability of polycationic complexes of an antisense oligonucleotide in rat small intestine homogenates. European Journal of Pharmaceutics and Biopharmaceutics, 55, 19–26.
   PubMed Web of Science ®Google Scholar
• GONZALEZ FERREIRO, M., TILLMAN, L., HARDEE, G., and BODMEIER, R., 2001, Characterization of complexes of an antisense oligonucleotide with protamine and poly-L-lysine salts. Journal of Controlled Release, 73, 381–390.
   PubMedGoogle Scholar
• JUNGHANS, M., KREUTER, J., and ZIMMER, A., 2000, Antisense delivery using protamineoligonucleotide particles. Nucleic Acids Research, 28, e45.
   PubMed Web of Science ®Google Scholar
• JUNGHANS, M., KREUTER, J., and ZIMMER, A., 2001, Phosphodiester and phosphorothioate oligonucleotide condensation and preparation of antisense nanoparticles. Biochimica et Biophysica Acta, 1544, 177–188.
   PubMed Web of Science ®Google Scholar
• LANGER, K., BALTHASAR, S., VOGEL, V., DINAUER, N., VON BRIESEN, H., and SCHUBERT, D., 2003, Optimization of the preparation process for human serum albumin (HSA) nanoparticles. International Journal of Pharmaceutics, 257, 169–180.
   PubMed Web of Science ®Google Scholar
• LEBEDEVA, I., and STEIN, C. A., 2001, Antisense oligonucleotides: promise and reality. Annual Review of Pharmacology and Toxicology, 41, 403–419.
   PubMed Web of Science ®Google Scholar
• LEBEDEVA, I., BENIMETSKAYA, L., STEIN, C. A., and VILENCHIK, M., 2000, Cellular delivery of antisense oligonucleotides. European Journal of Pharmaceutics and Biopharma-ceutics, 50, 101–119.
   PubMed Web of Science ®Google Scholar
• MARTIN, A., SWARBRICK, J., and CAMMARATA, A., 1983, Physical Pharmacy-Physical Chemical Principles in the Pharmaceutical Sciences (Philadelphia: Lea and Febriger).
   Google Scholar
• METELEV, V., and AGRAWAL, S., 1992, Ion-exchange high-performance liquid chromato-graphy analysis of oligodeoxyribonucleotide phosphorothioates. Analytical Biochemistry, 200, 342–346.
   PubMed Web of Science ®Google Scholar
• PECORA, R., 2000, Dynamic light scattering measurement of nanometer particles in liquids. Journal of Nanoparticle Research, 2, 123–131.
   Web of Science ®Google Scholar
• PRABHA, S., ZHOU, W. Z., PANYAM, J., and LABHASETWAR, V., 2002, Size-dependency of nanoparticlemediated gene transfection: studies with fractionated nanoparticles. International Journal of Pharmaceutics, 244, 105–115.
   PubMed Web of Science ®Google Scholar
• SCHACHMAN, H. K., 1959, Ultracentrifugation in Biochemistry (New York: Academic Press). SCHLINGENSIEPEN, R., BRYSCH, W., and SCHLINGENSIEPEN, K. H., 1997, Antisense-From Technology to Therapy. (Berlin: Blackwell Wissenschaft).
   Google Scholar
• ScHucK, P., 2000, Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophysical Journal, 78, 1606–1619.
   Google Scholar
• ScHucK, P., and ROSSMANITH, P., 2000, Determination of the sedimentation coefficient distribution by least-squares boundary modeling. Biopolymers, 54, 328–341.
   PubMed Web of Science ®Google Scholar
• SCHUCK, P., PERUGINI, M. A., GONZALES, N. R., HOWLETT, G. J., and SCHUBERT, D., 2002, Size distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems. Biophysical Journal, 82, 1096–1111.
   PubMed Web of Science ®Google Scholar
• TAMM, I., DORKEN, B., and HARTMANN, G., 2001, Antisense therapy in oncology: new hope for an old idea? Lancet, 358, 489–497.
   PubMed Web of Science ®Google Scholar
• VOGEL, V., GOHY, J. F., LOHMEIJER, B. G. G., VAN DEN BROEK, J. A., HAASE, W., SCHUBERT, U. S., and SCHUBERT, D., 2003, Metallo-supramolecular micelles: studies by analytical ultracentrifugation and electron microscopy. Journal of Polymer Science A, 41, 3159–3168.
   Google Scholar
• VOGEL, V., LANGER, K., BALTHASAR, S., SCHUCK, P., MÄCHTLE, W., HAASE, W., TZIATZIOS, C., and SCHUBERT, D., 2002, Characterisation of serum albumin nanoparticles by sedimentation velocity analysis and electron microscopy. Progress in Colloid and Polymer Science, 119, 31–36.
   Google Scholar
• WEHLING, K., KRAUSS, S., and WAGNER, K. G., 1976, Cooperative binding of fluorescein-labeled clupeine by DNA. Nucleic Acids Research, 3, 149–164.
   PubMed Web of Science ®Google Scholar
• ZAMECNIK, P. C., and STEPHENSON, M. L., 1978, Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proceedings of the National Academy of Sciences (USA), 75, 280–284.
   PubMed Web of Science ®Google Scholar
• ZOBEL, H. P., KREUTER, J., WERNER, D., NOE, C. R., KUMEL, G., and ZIMMER, A., 1997, Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleo-tides. Antisense Nucleic Acid Drug Development, 7, 483–493.
   PubMedGoogle Scholar